Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 585

Similar articles for PubMed (Select 11176485)

1.
2.

Predicting disease recurrence in intermediate and high-risk patients undergoing radical prostatectomy using percent positive biopsies: results from CaPSURE.

Grossfeld GD, Latini DM, Lubeck DP, Broering JM, Li YP, Mehta SS, Carroll PR.

Urology. 2002 Apr;59(4):560-5.

PMID:
11927314
3.

Predicting recurrence after radical prostatectomy for patients with high risk prostate cancer.

Grossfeld GD, Latini DM, Lubeck DP, Mehta SS, Carroll PR.

J Urol. 2003 Jan;169(1):157-63.

PMID:
12478126
4.
5.

Is ethnicity an independent predictor of prostate cancer recurrence after radical prostatectomy?

Grossfeld GD, Latini DM, Downs T, Lubeck DP, Mehta SS, Carroll PR.

J Urol. 2002 Dec;168(6):2510-5.

PMID:
12441951
6.
7.

Lack of association of prostate carcinoma nuclear grading with prostate specific antigen recurrence after radical prostatectomy.

Zhou M, Hayasaka S, Taylor JM, Shah R, Proverbs-Singh T, Manley S, Rubin MA.

J Urol. 2001 Dec;166(6):2193-7.

PMID:
11696734
9.

Optimizing patient selection for prostate monotherapy.

Lee AK, Schultz D, Renshaw AA, Richie JP, D'Amico AV.

Int J Radiat Oncol Biol Phys. 2001 Mar 1;49(3):673-7.

PMID:
11172948
10.

Preoperative model for predicting prostate specific antigen recurrence after radical prostatectomy using percent of biopsy tissue with cancer, biopsy Gleason grade and serum prostate specific antigen.

Freedland SJ, Terris MK, Csathy GS, Kane CJ, Amling CL, Presti JC Jr, Dorey F, Aronson WJ; Search Database Study Group.

J Urol. 2004 Jun;171(6 Pt 1):2215-20.

PMID:
15126788
11.

Percent of prostate needle biopsy cores with cancer is significant independent predictor of prostate specific antigen recurrence following radical prostatectomy: results from SEARCH database.

Freedland SJ, Aronson WJ, Terris MK, Kane CJ, Amling CL, Dorey F, Presti JC Jr; SEARCH Database Study Group.

J Urol. 2003 Jun;169(6):2136-41.

PMID:
12771735
12.
13.

Prediction of extraprostatic cancer by prostate specific antigen density, endorectal MRI, and biopsy Gleason score in clinically localized prostate cancer.

Horiguchi A, Nakashima J, Horiguchi Y, Nakagawa K, Oya M, Ohigashi T, Marumo K, Murai M.

Prostate. 2003 Jun 15;56(1):23-9.

PMID:
12746843
14.

[Correlation of the anatomo-pathological staging of radical prostatectomy specimens with the amount of cancer in the preoperative sextant biopsy].

Ojea Calvo A, Núñez López A, Domínguez Freire F, Alonso Rodrigo A, Rodríguez Iglesias B, Benavente Delgado J, Barros Rodríguez JM, Gómez-González MC, González Piñeiro A, Otero García M, Nogueira March JL.

Actas Urol Esp. 2003 Jun;27(6):428-37. Spanish.

PMID:
12918149
15.

The independent impact of extended pattern biopsy on prostate cancer stage migration.

Master VA, Chi T, Simko JP, Weinberg V, Carroll PR.

J Urol. 2005 Nov;174(5):1789-93; discussion 1793.

PMID:
16217288
16.

Extended prostate biopsy scheme improves reliability of Gleason grading: implications for radiotherapy patients.

King CR, McNeal JE, Gill H, Presti JC Jr.

Int J Radiat Oncol Biol Phys. 2004 Jun 1;59(2):386-91.

PMID:
15145152
17.
19.

Role of radical prostatectomy in patients with prostate cancer of high Gleason score.

Tefilli MV, Gheiler EL, Tiguert R, Banerjee M, Sakr W, Grignon D, Wood DP Jr, Pontes JE.

Prostate. 1999 Apr 1;39(1):60-6.

PMID:
10221268
20.

Improved clinical staging system combining biopsy laterality and TNM stage for men with T1c and T2 prostate cancer: results from the SEARCH database.

Freedland SJ, Presti JC Jr, Terris MK, Kane CJ, Aronson WJ, Dorey F, Amling CL; SEARCH Database Study Group.

J Urol. 2003 Jun;169(6):2129-35.

PMID:
12771734
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk